Skip to main content
Premium Trial:

Request an Annual Quote

Adaptive Biotechnologies: Mark Adams, Nancy Hill

Adaptive Biotechnologies has appointed Mark Adams as chief operating officer effective Jan. 25, 2021. Adams, 53, joined Adaptive in April 2020 as chief technical officer.  

Adams holds a PhD in cell biology from Baylor College of Medicine and completed his postdoc in computational biology at Boston University.

On Jan. 21, 2021, Adaptive and Nancy Hill, the firm's executive VP of operations and program management, agreed that her tenure will be terminated, effective March 2, 2021. Hill's termination is not the result of any material disagreement with the company regarding its operations, policies, or practices, Adaptive said in a filing with the US Securities and Exchange Commission.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.